Marshall Wace, LLP Inotiv, Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Inotiv, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 64,131 shares of NOTV stock, worth $101,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,131

Previous 153,381 58.19%

Holding current value

$101,326

Previous $1.68 Million 93.68%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.66 - $9.87 $148,155 - $880,897	-89,250 Reduced 58.19%	64,131 $106,000
Q1 2024 May 15, 2024	BUY	$3.27 - $11.04 $206,775 - $698,103	63,234 Added 70.15%	153,381 $1.68 Million
Q4 2023 Feb 14, 2024	BUY	$1.69 - $3.86 $117,686 - $268,798	69,637 Added 339.53%	90,147 $330,000
Q3 2023 Nov 14, 2023	BUY	$3.01 - $7.32 $3,599 - $8,754	1,196 Added 6.19%	20,510 $63,000
Q2 2023 Aug 14, 2023	SELL	$4.08 - $7.22 $26,054 - $46,106	-6,386 Reduced 24.85%	19,314 $92,000
Q1 2023 May 15, 2023	BUY	$4.18 - $8.64 $50,966 - $105,347	12,193 Added 90.27%	25,700 $111,000
Q4 2022 Feb 14, 2023	SELL	$3.77 - $22.1 $924,494 - $5.42 Million	-245,224 Reduced 94.78%	13,507 $66,000
Q3 2022 Nov 14, 2022	BUY	$9.81 - $26.17 $2.06 Million - $5.5 Million	210,004 Added 430.98%	258,731 $4.36 Million
Q2 2022 Aug 15, 2022	BUY	$9.56 - $25.91 $465,830 - $1.26 Million	48,727 New	48,727 $468,000
Q1 2022 May 16, 2022	SELL	$18.52 - $40.41 $62,912 - $137,272	-3,397 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.55 - $57.88 $103,778 - $196,618	3,397 New	3,397 $143,000

Others Institutions Holding NOTV

# of Institutions

Shares Held

4.54M

Call Options Held

73.9K

Put Options Held

36.2K

View Full List

About Inotiv, Inc.

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $40.4M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

More about NOTV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Inotiv, Inc. Transaction History